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Background: Low adherence to chronic kidney disease (CKD) guidelines may be due to unrecognized CKD and
lack of guideline awareness on the part of providers. The goal of this study was to evaluate the impact of provider
education and access to a CKD registry on guideline adherence.
Methods: We conducted a cluster randomized controlled trial at the Louis Stokes Cleveland VAMC. One of two
primary care clinics was randomized to intervention. Providers from both clinics received a lecture on CKD
guidelines at study initiation. Providers in the intervention clinic were given access to and shown how to use a CKD
registry, which identifies patients with CKD and is automatically updated daily. Eligible patients had at least one
primary care visit in the last year, had CKD based on eGFR, and had not received renal replacement therapy. The
primary outcome was parathyroid hormone (PTH) adherence, defined by at least one PTH measurement during the
12 month study. Secondary outcomes were measurement of phosphorus, hemoglobin, proteinuria, achievement of
goal blood pressure, and treatment with a diuretic or renin-angiotensin system blocker.
Results: There were 418 and 363 eligible patients seen during the study in the control and intervention clinics,
respectively. Compared to pre-intervention, measurement of PTH increased in both clinics (control clinic: 16% to
23%; intervention clinic: 13% to 28%). Patients in the intervention clinic were more likely to have a PTH measured
during the study (adjusted odds ratio = 1.53; 95% CI (1.01, 2.30); P= 0.04). However, the intervention was not
associated with a consistent improvement in secondary outcomes. Only 5 of the 37 providers in the intervention
clinic accessed the registry.
Conclusions: An intervention that included education on CKD guidelines and access to a CKD patient registry
marginally improved guideline adherence over education alone. Adherence to the primary process measure
improved in both clinics, but no improvement was seen in intermediate clinical outcomes. Improving the care of
patients with CKD will likely require a multifaceted approach including system redesign.
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Chronic kidney disease (CKD) is common and increasing
in prevalence [1]. CKD is associated with a) increased
cardiovascular morbidity and mortality, b) increased risk
for end-stage renal disease, and c) metabolic complica-
tions [2,3]. Given the complex nature of CKD, the Na-
tional Kidney Foundation published the Kidney Disease
Outcome Quality Initiative (KDOQI) guidelines to
provide a framework for the clinical management of
patients with CKD [4]. The KDOQI guidelines make
recommendations for the evaluation, monitoring, and
management of patients with CKD.
Despite the dissemination of the KDOQI guidelines
and efforts by the National Kidney Foundation and the
American Society of Nephrology to raise awareness of the
importance of CKD, adherence to KDOQI recommenda-
tions is low [5-9]. Adherence is low across multiple areas
including monitoring for metabolic complications and
blood pressure control [5,10]. As expected, patients seen
by nephrologists are more likely to receive guideline ad-
herent care [8,9,11]. But, while adherence to recom-
mended process measures is better amongst patients seen
by nephrologists, achieving KDOQI targets is difficult even
when patients are seen in dedicated CKD clinics [7-9,12].
Low adherence to guidelines may be due to multiple fac-
tors including clinical inertia, competing demands,
unrecognized CKD, and lack of guideline awareness [13].
Patients with CKD often have multiple comorbidities such
as diabetes, hypertension, and cardiovascular disease [14].
These comorbidities may take precedence over routine
management of CKD in clinic visits with limited time.
Additionally, CKD is typically an asymptomatic disorder
and often goes unrecognized by primary care providers
[15,16]. Lack of guideline awareness by providers may also
contribute to non-adherence [17]. Lack of guideline
awareness varies across different domains with greater
awareness of blood pressure targets and lower awareness
of the indications for nephrology referral [15,18]. Provider
characteristics, such as younger age and internal medicine
training, are associated with increased guideline awareness
[15]. Finally, many of the KDOQI recommendations are
opinion based and low adherence may reflect providers’
differing interpretation of the literature.
Electronic health records have the potential to
improve the care of patients with chronic medical condi-
tions [19]. Chronic disease registries facilitate the identi-
fication of patients with chronic conditions and have
been shown to be critical components of quality im-
provement efforts [20]. We hypothesized that access to a
CKD registry would increase guideline adherence by giv-
ing primary care providers a tool to easily identify their
patients with CKD while also offering decision support
tools. The goal of this study was to evaluate the impact
of provider education and access to a CKD registry onKDOQI guideline adherence when compared to educa-
tion alone.
Methods
We conducted a cluster randomized controlled trial
evaluating the impact of a multifactorial intervention on
CKD guideline adherence. The study was conducted in
the primary care outpatient clinics at the Wade Park
Veterans Affairs Medical Center (VAMC) in Cleveland.
The study was approved by the Louis Stokes Cleveland
VAMC institutional review board. A waiver of consent
was approved for patients. Verbal consent was obtained
from all providers.
Patients are assigned to a primary care clinic on the
basis of the last digit of their social security number
(even numbers to Firm A, odd numbers to Firm B). Staff
physicians, nurse practitioners, and internal medicine
residents provide patient care. Providers are assigned to
Firm A or B based on need at the time of their hiring.
Simple randomization based on a probability of 0.50 was
used to assign Firm A to intervention or control with
Firm B then assigned to the other arm. In addition to
the study clinics (intervention and control), a commu-
nity cohort was evaluated for guideline adherence prior
to and during the study period. The community cohort
consisted of patients seen in any of the 14 community
based outpatient centers (CBOCs) located in Northeast
Ohio. CBOC providers did not participate in any study
procedures. All patients were blinded as were data col-
lection activities. Providers were unaware of the out-
come measures but, given the nature of the study, were
not blinded to study group assignment.
All Firm A and B primary care providers were eligible.
Patients were eligible if they a) had at least one visit to a
Wade Park VAMC primary care clinic during the study
period, b) had CKD as defined by a most recent esti-
mated glomerular filtration rate (eGFR) less than 60 mL/
min per 1.73 m2 with another eGFR less than 60 mL/
min per 1.73 m2 between 90 and 730 days previously,
and c) had not received renal replacement therapy [21].
Intervention
The multifactorial intervention included provider educa-
tion, academic detailing, and access to a CKD registry
designed to facilitate guideline adherence. The control
group received the education only. All primary care pro-
viders, including the control group, received an educa-
tional lecture which was given daily for a week during
the first month of the study (July 2009). The lecture was
organized around a CKD guideline reference card that
was distributed to all providers (see Additional file 1).
Providers in the intervention group were also given ac-
cess to and shown how to use the CKD registry which
was available from July 1, 2009 until June 30, 2010. The
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received academic detailing which focused on general
CKD guidelines and blood pressure management (Janu-
ary, 2010) and bone and mineral disease (March, 2010).
The study period went from July 1, 2009 until June 30,
2010. For comparison purposes, a pre-intervention
period was defined as July 1, 2008 until June 30, 2009.CKD registry
All patients in Veterans Integrated Service Network 10
(VISN 10) whose last eGFR is less than 60 mL/min per
1.73 m2 with a second eGFR less than 60 greater than 3
months prior are automatically entered into a CKD regis-
try. The registry was designed and user-tested prior to
study initiation and includes demographic and clinical in-
formation essential to the care of patients with CKD –
age, transplant status, dialysis status, medications, aller-
gies/adverse reactions to angiotensin converting enzyme
inhibitors/angiotensin receptor blockers (ACEI/ARB), and
most recent eGFR, blood pressure, calcium, phosphorous,
parathyroid hormone (PTH), hemoglobin, and urine albu-
min to creatinine ratio. The registry is updated on a daily
basis and was made available to residents, physicians, and
nurse practitioners in the intervention group via the se-
cure VA intranet. All examination and work rooms in-
clude computers with intranet access. Providers were able
to search for all of their CKD patients or a subset based
on level of kidney function, most recent systolic blood
pressure, most recent PTH, or most recent hemoglobin. A
similar diabetes registry is used on a daily basis by nurses
at 14 CBOCs located throughout Northeast Ohio.Data collection
The primary outcome was PTH adherence, defined by at
least one PTH measured during the 12 month study
period. PTH adherence was chosen because it is rela-
tively specific to the care of patients with CKD and the
rate of PTH adherence has been documented to be low.
Secondary outcomes included measurement of phos-
phorus, hemoglobin, and urine protein, achievement of
goal blood pressure (< 130/80 mmHg), and treatment
with a diuretic or an angiotensin converting enzyme in-
hibitor or angiotensin receptor blocker (ACEI/ARB) dur-
ing the 12 month study period.
Demographic and clinical data were collected from the
VISN 10 data warehouse. Blood pressure and laboratory
values were defined as the most recent value during the
study period. For eGFR, the average during the study
period was calculated. Diabetes was defined by two or
more ICD-9 codes (250–250.99) or receipt of two or
more diabetes medications. Hypertension was defined by
two or more ICD-9 codes (401–405.99) or a most recent
clinic blood pressure greater than 130/80 mmHg withone prior clinic blood pressure greater than 130/80
mmHg. Coronary artery disease (410–414.99 or 429.2)
and cancer (140–208, 230–234, or V10) were defined by
2 or more ICD-9 codes. Patients with end-stage renal
disease were identified for exclusion by chart review of
all subjects with an eGFR less than 15 mL/min per 1.73
m2 and by searching the dialysis and transplant list in
the VISN 10 data warehouse. Note titles were used to
identify subjects seen by nephrology or treated in the
emergency department.
Statistical analyses
Characteristics of eligible patients were reported using
means (standard deviations) or percentages and were
compared using two-sample t tests, Wilcoxon tests, or
Pearson chi-squared tests as appropriate. To adjust for
correlation among responses obtained prior to and during
the study period within the same patient, a Generalized
Estimating Equation (GEE) approach was used to estimate
the effect of intervention (intervention clinic vs. control
clinic) on the odds of having a PTH measured during the
12 month study period. The model treated subjects as
clusters and included fixed effects for time, intervention,
and an interaction between time and intervention. This
model also provides an estimate of the probability of hav-
ing a PTH test measured prior to and during the study
period. Models were extended to include additional ad-
justment for factors that might influence adherence to
guidelines including age, gender, race, diabetes, coronary
artery disease, cancer, eGFR, proteinuria, last systolic
blood pressure, whether subjects were seen by nephrology
during the study period, and whether subjects were seen
in the emergency department during the study period. To
evaluate for secular trends, the effect of being in the con-
trol clinic vs. a CBOC on the odds of having a PTH mea-
sured during the 12 month study was also assessed using a
GEE approach.
Results
All primary care providers at the Wade Park Veterans
Affairs Medical Center were eligible for the study: 56 in-
ternal medicine residents, 8 physicians, and 6 nurse
practitioners. All agreed to participate and were verbally
consented. Twenty of 37 providers (54%) in the inter-
vention clinic and 17 of 33 providers (52%) in the con-
trol clinic attended the lecture on CKD guidelines. All
providers were given the CKD guideline reference card;
providers unable to attend a lecture were given the CKD
reference card at a later date at which time the content
of the lecture was briefly discussed. All intervention
clinic providers were shown how the registry could be
used to identify their patients with CKD and how to
search for patients who had not received guideline
recommended care. Only 5 of the 37 providers in the
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12 month study.
During the study, 418 eligible subjects were seen in
the control clinic and 363 eligible subjects were seen in
the intervention clinic (see Figure 1). All subjects were
included in the CKD registry. The demographic and
clinical characteristics of the eligible subjects are shown
in Table 1. The two groups were similar with regard to
most characteristics including age, gender, race, eGFR,
and blood pressure. Subjects in the control clinic were
less likely to have hypertension (93.1% vs 97.0%) and
coronary artery disease (31.6% vs 40.8%).
The probability of having a PTH measured increased
from pre-intervention to the study period in both the
control (0.16 to 0.23, P= 0.01) and intervention (0.13 to
0.28, P < 0.001) clinics. The unadjusted odds ratio (OR)
for having at least one PTH during the 12 month study
associated with being in the intervention clinic was 1.35
(95% CI: 0.98 to 1.86; P= 0.07) (see Table 2). There was
little change after adjusting for age, race, and gender or
in a fully adjusted model. The effect of the intervention
was more pronounced among patients seen by physi-
cians and nurse practitioners (OR= 1.68; 95% CI: 1.04 to
2.72) than among patients seen by internal medicine
residents (OR= 1.02; 95% CI: 0.55 to 1.87) but the differ-
ence in these effects was not statistically significant.
Patients (n = 74) seen by one of the five providers who
accessed the registry during the study period were more
likely to have a PTH measured (OR= 2.33; 95% CI: 1.37
to 3.97). For these five providers, it is not possible to de-
termine whether accessing the registry led to improved
adherence or, alternatively, that these providers were
more engaged in the management of CKD.8,086 patients seen in clinic between
July 1, 2009 and July 1, 2010
188 – no eGFR
7,898 subjects
781 subjects included in the present
analyses
6,804 – most recent eGFR > 60




Figure 1 CONSORT diagram.For the majority of the secondary outcomes, there was
no change during the study period compared to pre-
intervention for either the control or intervention clinics
(see Table 3). The percent of subjects with a phosphorus
or urine protein measurement increased in the interven-
tion clinic but not the control clinic while the percent of
subjects treated with an ACEI/ARB decreased in the
control clinic. In addition, there were no consistent dif-
ferences in the intervention effect on secondary
outcomes such as measurement of phosphorus or
hemoglobin, achievement of goal blood pressure, or
treatment with an ACEI/ARB (see Table 4). Patients in
the intervention clinic were less likely to have had an
evaluation for proteinuria during the study (adjusted
OR=0.61; 95% CI: 0.43 to 0.87). On the other hand,
patients in the intervention clinic were more likely to be
on a diuretic (adjusted OR= 1.57; 95% CI: 1.12 to 2.18).
Finally, 7,994 patients with CKD were seen at a CBOC
in Northeast Ohio during the study period. While PTH
adherence improved in these community clinics during
the study compared to pre-intervention (4.3% vs 5.4%,
P < 0.001), the odds ratio for having at least one PTH
during the study associated with being in the control
clinic compared to these community clinics was 4.34
(95% CI: 3.19 to 5.89; P < 0.001). Therefore, while there
may have been increasing adherence for the primary
process measure in the community, the improvement in
adherence observed in the control clinic was above and
beyond this secular trend.
Discussion
This cluster randomized controlled study demonstrates
that provider education and access to a CKD registry
improved adherence to KDOQI guidelines for the pri-
mary process measure (PTH adherence) more than
education alone. However, there was no consistent im-
provement in adherence to guidelines for secondary pro-
cesses or intermediate clinical outcomes. Education was
provided to clinicians in both the control and interven-
tion clinic and improvement in guideline adherence was
observed in both groups. A slight improvement in guide-
line adherence was also seen in a contemporaneous
community cohort that was not involved in any study
procedures. However, while there may have been a secu-
lar trend towards improved KDOQI guideline adherence,
it was of lower magnitude than that observed in the
study clinics.
Low adherence to KDOQI guidelines may be due to
lack of awareness and familiarity with the guidelines [22].
Given that these factors may be modifiable, researchers
evaluated the impact of academic detailing and feedback
to providers on guideline adherence [23]. After one year,
significant improvement was seen across multiple areas
including diagnosis of CKD (from 38% to 70%) and
Table 1 Demographic and clinical characteristics of CKD patients seen in control and intervention clinics during the
study period
Variable Control clinic Intervention clinic P value
(n = 418) (n = 363)
Age (years) 71.0 (10.3) 71.0 (10.7) 0.99
Gender (% male (N)) 95.9% (401) 94.5% (343) 0.34
Race (% black (N)) 45.9% (192) 44.9% (163) 0.77
Past Medical History (% (N))
Diabetes 50.2% (210) 44.9% (163) 0.14
Hypertension 93.1% (389) 97.0% (352) 0.013
Coronary artery disease 31.6% (132) 40.8% (148) 0.008
Cancer 21.1% (88) 21.8% (79) 0.81
Last systolic BP (mmHg) 133.1 (18.4) 132.4 (17.9) 0.63
Last diastolic BP (mmHg) 72.8 (11.7) 71.6 (12.2) 0.17
Renal function
Average eGFR during study period* 47.8 (40, 56) 48.1 (39, 55) 0.40
Stage of CKD (%)
III 91.6% 89.5% 0.52
IV 7.7% 9.9%
V 0.7% 0.6%
Proteinuria 24.2% 20.7% 0.24
Most recent laboratory results
PTH* 104 (61, 184) 95 (62, 156) 0.74
Phosphorus 3.7 (0.7) 3.7 (0.7) 0.54
Hemoglobin 12.8 (1.9) 12.6 (1.8) 0.35
Number of clinic visits during study period 2.4 (1.4) 2.3 (1.4) 0.30
Seen by nephrology during the study period 16.3% 19.8% 0.19
Seen in urgent care during the study period 49.8% 52.9% 0.38
* Median (25th, 75th percentile), Wilcoxon test.
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44%). These results are consistent with our finding of
improved adherence in the control and intervention
clinics, both of which received provider education. How-
ever, in the previous study, improvement plateaued, and
even regressed slightly, two years later [23]. The challenge
will be to develop sustainable interventions that propel
clinical care to expected levels of quality, not just im-
provement above a poor baseline performance. Provider
education is a necessary component of any program toTable 2 Odds ratio (95% confidence interval) for having a PT




Age, race, gender, diabetes, coronary artery
disease, cancer, eGFR, proteinuria, ED visit in
the last year, seen by nephrology, last SBPimprove the care of patients with CKD but is likely not
sufficient on its own.
In our study, providing access to an electronic CKD
registry improved adherence to guideline recommended
care for the primary process measure but not for sec-
ondary process measures or clinical outcomes. Previous
qualitative research has identified information technol-
ogy and disease registries as being critical factors in the
success of quality improvement efforts [20]. However,
successful quality improvement programs are typicallyH test measured comparing intervention vs control clinic
Odds ratio (95% CI) P value
1.35 (0.98, 1.86) 0.071
1.40 (1.00, 1.96) 0.047
1.53 (1.01, 2.30) 0.04
Table 3 Secondary process measures and clinical outcomes pre-Intervention and during the study period





Last BP <130/80 mmHg 0.39 (0.33, 0.45) 0.41 (0.36, 0.46) 0.44 (0.38, 0.50) 0.44 (0.39, 0.49)
% of subjects with lab test in the last year
Phosphorus 0.66 (0.60, 0.72) 0.70 (0.66, 0.75) 0.59 (0.53, 0.65) 0.75 (0.71, 0.79)*
Urine protein 0.72 (0.67, 0.78) 0.72 (0.67, 0.76) 0.56 (0.50, 0.62) 0.63 (0.58, 0.68)*
Hemoglobin 0.82 (0.76, 0.86) 0.80 (0.76, 0.84) 0.85 (0.80, 0.89) 0.84 (0.79, 0.87)
Subjects on a diuretic 0.71 (0.66, 0.76) 0.68 (0.63, 0.72) 0.77 (0.72, 0.81) 0.75 (0.71, 0.79)
Subjects on an ACEI/ARB 0.81 (0.76, 0.85) 0.75 (0.71, 0.79)* 0.77 (0.72, 0.82) 0.78 (0.74, 0.82)
Subjects with diabetes or proteinuria on an ACEI/ARB 0.89 (0.84, 0.93) 0.85 (0.80, 0.89) 0.86 (0.78, 0.91) 0.88 (0.83, 0.92)
* P value < 0.05 pre-intervention to study period within clinic.
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tion, funding, partnerships, and health care delivery sys-
tem reform [20]. A recent study demonstrated no
consistent improvement in quality of CKD care with a
clinical decision support system embedded within the
electronic medical record [24]. Our quantitative study
also suggests that advances in information systems, by
themselves, are not sufficient for comprehensive quality
improvement. Many providers and health care organiza-
tions are currently purchasing electronic health records
and working to achieve “meaningful use”. Our results
are important because they demonstrate that the ability
to “generate lists of patients by specific conditions”, one
of many stage 1 meaningful use criteria, [25] does not
necessarily translate to actual use by providers or im-
provement in quality of care. Perhaps the meaningful
use criterion needs to be modified to include not only
the generation of lists but their actual use by providers.
The lack of improvement in guideline adherence in
our study may be due to a lack of system redesign. Pro-
viders were not given protected time to access the CKD
registry nor was there reorganization of the clinic toTable 4 Odds ratio (95% confidence interval) for secondary p




Last BP < 130/80 mmHg 1.15 (0.86,
% of subjects with lab test in the last year
Phosphorus 1.32 (0.95,
Urine protein 0.66 (0.49,
Hemoglobin 1.23 (0.85,
Subjects on a diuretic 1.50 (1.08,
Subjects on an ACEI/ARB 1.22 (0.87,
Subjects with diabetes or proteinuria on an ACEI/ARB 1.27 (0.72,
Model 1: Adjusted for age, gender, race.
Model 2: Adjusted for age, gender, race, diabetes, coronary artery disease, cancer, eprovide ancillary support or a multidisciplinary team
that could utilize the registry. Physicians and other pri-
mary providers receive only minimal training in public
health and little if any training in population or panel
management. Medical education focuses primarily on
the pathology of disease and the diagnosis and manage-
ment of individual patients. Therefore, translating new
information technologies, such as disease registries, into
improvements in processes of care and clinical outcomes
will require redesigning medical education to include
population management. Additionally, delivery system
redesign is needed to provide ancillary resources and
modify the clinic work flow to capitalize on the wealth
of information now available from electronic health
records. It is likely that both provider education and sys-
tem redesign will be required to fully realize the benefits
of new information technologies.
This study has limitations that need to be considered.
The intervention was limited to education and a disease
registry and did not include other components of the
chronic care model such as delivery system redesign, dir-
ect patient education, and self-management support [26].rocess and clinical outcomes comparing intervention vs
Model 2
P value Odds ratio P value
(95% CI)
1.53) 0.34 1.12 (0.84, 1.49) 0.44
1.83) 0.10 1.25 (0.89, 1.77) 0.20
0.90) 0.009 0.61 (0.43, 0.87) 0.006
1.78) 0.28 1.08 (0.72, 1.61) 0.71
2.07) 0.02 1.57 (1.12, 2.18) 0.008
1.70) 0.25 1.29 (0.91, 1.83) 0.15
2.23) 0.41 1.34 (0.75, 2.40) 0.32
GFR, proteinuria, ED visit in the last year, seen by nephrology.
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of improvement, it did allow for an independent evalu-
ation of the impact of access to an electronic disease regis-
try on processes and outcomes of care. Many of the
clinical variables were not measured at the same time for
all subjects and were instead measured using data col-
lected over the entire 12 month study period. Because
there were only two clinics, the effect of clinic could not
be properly accounted for. While there were only 2 clinics,
they did include various models of care delivery including
primary care physicians, nurse practitioners, and super-
vised medicine residents. The duration of the study is lim-
ited and does not allow for an evaluation of long term
effects of a chronic disease registry. The outcomes do not
include any hard endpoints such as mortality or end-stage
renal disease. Medicine residents may have been over-
whelmed by the complex medical care required for
patients with CKD and therefore unable to take advantage
of the CKD registry. Finally, the study was quantitative in
nature and does not include any qualitative assessment of
providers’ interactions with the registry.
The main strength of this study is the use of a control
clinic. Many studies of quality improvement efforts are
limited by their use of historical controls. Use of a con-
trol clinic allows for a direct evaluation of the impact of
access to a CKD registry on guideline adherence. In
addition, we were able to monitor use of the CKD regis-
try and demonstrate that most providers did not utilize
the new technology. Finally, this study included a large
number of patients and a diverse group of providers in-
cluding internal medicine residents, physicians, and
nurse practitioners.Conclusions
In conclusion, this randomized controlled trial demon-
strates that a quality improvement effort including pro-
vider education and access to a CKD registry may
improve some aspects of CKD care compared to educa-
tion alone. However, the improvement achieved still fell
below expected performance levels, was not consistent
across multiple measures of adherence, and did not trans-
late into improved intermediate clinical outcomes. These
results will inform future development and implementa-
tion of disease registries. Providing electronic medical
record based tools without system level changes, such as
protected time for panel management, is insufficient to
improve quality of care. To achieve high performance
levels, it is likely that a more comprehensive quality im-
provement program is necessary for patients with CKD.
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